Bioavailability and its assessment

Journal of Veterinary Pharmacology and Therapeutics

Volumn 27, Issue 6, 2004, Pages 455-466

  Toutain, P L ^a   Bousquet Melou A ^a  

^a CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DRUG;

AREA UNDER THE CURVE; BIOEQUIVALENCE; CONFERENCE PAPER; CURVE FITTING; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DISPOSITION; DRUG EFFECT; NONHUMAN; NONLINEAR SYSTEM; PRIORITY JOURNAL; REPRODUCIBILITY; RISK ASSESSMENT; SYSTEMIC CIRCULATION; VENOUS BLOOD; VETERINARY MEDICINE;

ANIMALS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; MODELS, ANIMAL; MODELS, BIOLOGICAL; VETERINARY DRUGS;

EID: 10844248241     PISSN: 01407783     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2004.00604.x     Document Type: Conference Paper

References (40)

1. Anonymous (2001) Note for guidance on the investigation of bioavailability and bioequivalence. In Evaluation of Medicines for Human Use Committee for Proprietary Medicinal Products. pp. 1-18. The European Agency for the Evaluation of Medicinal Products, London.
2. Baggot, J.D. (2001) The Physiological Basis of Veterinary Clinical Pharmacology. Blackwell Science, Oxford.
3. Bai, S.A., Walle, U.K. & Walle, T. (1985) Influence of food on the intravenous and oral dose kinetics of propranolol in the dog. Journal of Pharmacokinetics and Biopharmaceutics, 13, 229-241.
4. Bailey, D.G., Dresser, G.K., Kreeft, J.H., Munoz, C., Freeman, D.J. & Bend, J.R. (2000) Grapefruit-felodipine interaction: effect of unprocessed fruit and probable active ingredients. Clinical Pharmacology and Therapeutics, 68, 468-477.
5. Bonnin, P., Huynh, L., L'Haridon, R., Chene, N. & Martal, J. (1999) Transport of uterine PGF2 alpha to the ovaries by systemic circulation and local lymphovenous-arterial diffusion during luteolysis in sheep. Journal of Reproduction and Fertility, 116, 199-210.
6. Brouwer, K.R. & McNamara, P.J. (1986) Use of simultaneous computer fitting to estimate the apparent absorption rate constant. Journal of Pharmaceutical Sciences, 75, 452-455.
7. Burtin, P., Mentre, F., van Bree, J. & Steimer, J.L. (1996) Sparse sampling for assessment of drug exposure in toxicological studies. European Journal of Drug Metabolism and Pharmacokinetics, 21, 105-111.
8. Chiou, W.L. (2001) The rate and extent of oral bioavailability versus the rate and extent of oral absorption: clarification and recommendation of terminology. Journal of Pharmacokinetics and Biopharmaceutics, 28, 3-6.
9. Cutler, D. (1981) Assessment of rate and extent of drug absorption. Pharmacology and Therapeutics, 14, 123-160.
10. Doki, K., Hayakawa, T., Lin, W., Yanaguimoto, H., Ding, G. & Inotsume, N. (2003) Effects of absorption rate on the pre-systemic chiral inversion of ibuprofen in rabbits. Journal of Pharmacy and Pharmacology, 55, 1091-1097.
11. Dupuy, J., Larrieu, G., Sutra, J.F., Lespine, A. & Alvinerie, M. (2003) Enhancement of moxidectin bioavailability in lamb by a natural flavonoid: quercetin. Veterinary Parasitology, 112, 337-347.
12. Garrett, E.R. (1994) The Bateman function revisited: a critical reevaluation of the quantitative expressions to characterize concentrations in the one compartment body model as a function of time with first-order invasion and first-order elimination. Journal of Pharmacokinetics and Biopharmaceutics, 22, 103-128.
13. Gibaldi, M. & Perrier, D. (1982) Pharmacokinetics, 2nd edn. Marcel Dekker, New York.
14. Gibson, D.M., Taylor, M.E. & Colburn, W.A. (1987) Curve fitting and unique parameter identification. Journal of Pharmaceutical Sciences, 76, 658-659.
15. Hellriegel, E.T., Bjornsson, T.D. & Hauck, W.W. (1996) Interpatient variability in bioavailability is related to the extent of absorption: implications for bioavailability and bioequivalence studies. Clinical Pharmacology and Therapeutics, 60, 601-607.
16. Hinderling, P.H. (2003) Evaluation of a novel method to estimate absolute bioavailability of drugs from oral data. Biopharmaceutics and Drug Disposition, 24, 1-16.
17. Hinderling, P.H. & Shi, J. (1995) Absolute bioavailability estimated from oral data. Journal of Pharmaceutical Sciences, 84, 385-386.
18. Karlsson, M.O. & Bredberg, U. (1990) Bioavailability estimation by semisimultaneous drug administration: a Monte Carlo simulation study. Journal of Pharmacokinetics and Biopharmaceutics, 18, 103-120.
19. Karlsson, M.O. & Sheiner, L.B. (1994) Estimating bioavailability when clearance varies with time. Clinical Pharmacology and Therapeutics, 55, 623-637.
20. Kilroy, C.R., Hall, W.F., Bane, D.P., Bevill, R.F. & Koritz, G.D. (1990) Chlortetracycline in swine - bioavailability and pharmacokinetics in fasted and red pigs. Journal of Veterinary Pharmacology and Therapeutics, 13, 49-58.
21. Liang, E. & Derendorf, H. (1998) Pitfalls in pharmacokinetic multicompartment analysis. Journal of Pharmacokinetics and Biopharmaceutics, 26, 247-260.
22. Lovering, E.G., McGilveray, I.J., McMillan, I. & Tostowaryk, W. (1975) Comparative bioavailabilities from truncated blood level curves. Journal of Pharmaceutical Sciences, 64, 1521-1524.
23. Madden, F.N., Godfrey, K.R., Chappell, M.J., Hovorka, R. & Bates, R.A. (1996) A comparison of six deconvolution techniques. Journal of Pharmacokinetics and Biopharmaceutics, 24, 283-299.
24. Martinez, M.N. (1998) Article V: clinically important errors in data interpretation. Journal of American Veterinary Medical Association, 213, 1564-1569.
25. Martinez, M.N. & Jackson, A.J. (1991) Suitability of various noninfinity area under the plasma concentration-time curve (AUC) estimates for use in bioequivalence determinations: relationship to AUC from zero to time infinity (AUCO-INF). Pharmacological Research, 8, 512-517.
26. Murata, K. & Kohno, K. (1989) Estimation problem due to multiple solutions in pharmacokinetic curve fitting to two-compartment model and its avoidance. Biopharmaceutics and Drug Disposition, 10, 15-24.
27. Purves, R.D. (1992) Optimum numerical integration methods for estimation of area-under-the-curve (AUC) and area-under-the-moment-curve (AUMC). Journal of Pharmacokinetics and Biopharmaceutics, 20, 211-226.
28. Riegelman, S. & Collier, P. (1980) The application of statistical moment theory to the evaluation of in vivo dissolution time and absorption time. Journal of Pharmacokinetics and Biopharmaceutics, 8, 509-534.
29. Rowland, M. & Tozer, T.N. (1995) Clinical Pharmacokinetics. Concepts and Applications, 3rd edn. Williams and Wilkins, London.
30. Toutain, P.L. & Koritz, G.D. (1997) Veterinary drug bioequivalence determination. Journal of Veterinary Pharmacology and Therapeutics, 20, 79-90.
31. Toutain, P.L., Koritz, G.D., Fayolle, P.M. & Alvinerie, M. (1986) Pharmacokinetics of methylprednisolone, methylprednisolone sodium succinate, and methylprednisolone acetate in dogs. Journal of Pharmaceutical Sciences, 75, 251-255.
32. Toutain, P.L., Lefebvre, H.P. & King, J.N. (2000) Benazeprilat disposition and effect in dogs revisited with a pharmacokinetic/pharmacodynamic modeling approach. Journal of Pharmacology and Experimental Therapeutics, 292, 1087-1093.
33. Toutain, P.L. & Bousquet-Mélou, A. (2004) Plasma clearance. Journal of Veternary Pharmacology and Therapeutics, 27, 415-425.
34. Veng-Pedersen P. (1989a) Mean time parameters in pharmacokinetics. Definition, computation and clinical implications (Part II). Clinical Pharmacokinetics, 17, 345-366.
35. Veng-Pedersen, P. (1989b) Mean time parameters in pharmacokinetics. Definition, computation and clinical implications (Part II). Clinical Pharmacokinetics, 17, 424-440.
36. Wagner, J.G. (1967) Method of estimating relative absorption of a drug in a series of clinical studies in which blood levels are measured after single and/or multiple doses. Journal of Pharmaceutical Sciences, 56, 652-653.
37. Wagner, J.G. (1983) Pharmacokinetic absorption plots from oral data alone or oral/intravenous data and an exact Loo-Riegelman equation. Journal of Pharmaceutical Sciences, 72, 838-842.
38. Weiss, M. (1990) Use of metabolite AUC data in bioavailability studies to discriminate between absorption and first-pass extraction. Clinical Pharmacokinetics, 18, 419-422.
39. Yamaoka, K., Nakagawa, T. & Uno, T. (1978) Statistical moments in pharmacokinetics. Journal of Pharmacokinetics and Biopharmaceutics, 6, 547-558.
40. Yeh, K.C. & Kwan, K.C. (1978) A comparison of numerical integrating algorithms by trapezoidal, Lagrange, and spline approximation. Journal of Pharmacokinetics and Biopharmaceutics, 6, 79-98.